Adjuvant radiotherapy in patients with pathologic Stage C (pT3N0) adenocarcinoma of the prostate (Q41672124)

6 October 2017

title

Adjuvant radiotherapy in patients with pathologic Stage C (pT3N0) adenocarcinoma of the prostate (English)

1 reference

6 October 2017

Petrovich Z

1

1 reference

6 October 2017

Lieskovsky G

2

1 reference

6 October 2017

Langholz B

3

1 reference

6 October 2017

Bochner B

4

1 reference

6 October 2017

Formenti S

5

1 reference

6 October 2017

Streeter O

6

1 reference

6 October 2017

Skinner DG

7

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

6 October 2017

1 reference

6 October 2017

volume

53

1 reference

6 October 2017

issue

6

1 reference

6 October 2017

page(s)

1184-1193

1 reference

Of historical interest. General Grant fights cancer

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the Commission on Cancer National Cancer Database, 1985-1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Surgical treatment of locally advanced (T3) prostatic carcinoma: early results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Course of localized adenocarcinoma of the prostate treated by radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Radiotherapy following radical prostatectomy in patients with adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PcN0) prostate cancer from 1976 to 1989: intermediate findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Surgery with adjuvant irradiation in patients with pathologic stage C adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Adjuvant radiotherapy following radical prostatectomy: results and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Staging of early prostate cancer: a proposed tumor volume-based prognostic index

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Diagnostic testing for prostate cancer detection: Less is best

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

The role of external beam radiation therapy after prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Postoperative radiation therapy for pathologic stage C prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

The role of adjuvant irradiation following primary prostatectomy, based on histopathologic extent of tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Adjuvant radiotherapy in patients post radical prostatectomy with tumor extending through capsule or positive seminal vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: Analysis of freedom from psa failure

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Adjuvant radiotherapy following radical prostatectomy--results of 56 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

The result of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900011-4

7 January 2021

10.1016/S0090-4295(99)00011-4

Identifiers

DOI

1 reference

6 October 2017

1 reference